Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

24 trials with published results (14%)

Research Maturity

119 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.4%

4 terminated out of 169 trials

Success Rate

96.7%

+10.2% vs benchmark

Late-Stage Pipeline

12%

20 trials in Phase 3/4

Results Transparency

20%

24 of 119 completed with results

Key Signals

24 with results97% success

Data Visualizations

Phase Distribution

143Total
Not Applicable (82)
Early P 1 (3)
P 1 (22)
P 2 (16)
P 3 (8)
P 4 (12)

Trial Status

Completed119
Unknown26
Recruiting11
Active Not Recruiting7
Terminated4
Withdrawn1

Trial Success Rate

96.7%

Benchmark: 86.6%

Based on 119 completed trials

Clinical Trials (169)

Showing 20 of 20 trials
NCT07608705Phase 1CompletedPrimary

A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants

NCT07322016Phase 1CompletedPrimary

A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

NCT06643806Not ApplicableCompleted

Implementation of a Peer Leader-facilitated Dyadic Intervention

NCT05015348Not ApplicableCompletedPrimary

Effect of Omega-3 Supplementation on Fasting Triglycerides During Lifestyle Intervention in Adults With Mild-to-moderate Hypertriglyceridemia

NCT05820295Not ApplicableCompleted

Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination

NCT05457582Not ApplicableActive Not Recruiting

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI

NCT06461273Not ApplicableCompleted

Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome

NCT06094491Not ApplicableActive Not Recruiting

Virtual Diabetes Group Visits Across Health Systems

NCT07578857Not ApplicableCompletedPrimary

Combined Effects of Withania Somnifera & Syzgium Cumini on Hyperlipidemia

NCT06903897Not ApplicableRecruitingPrimary

Social Needs Screening and Chronic Diseases Study (WE CARE)

NCT05643508Phase 3Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia

NCT04608474Phase 4CompletedPrimary

Lipid Management in Renal Transplant Recipients Using Evolocumab.

NCT06062394Not ApplicableRecruiting

Penn Medicine Healthy Heart

NCT05703386Recruiting

Imaging the Pathogenesis of Cerebral Small Vessel Disease

NCT06347484Not ApplicableActive Not Recruiting

Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)

NCT07295418Phase 3CompletedPrimary

A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia

NCT05537064Not ApplicableActive Not RecruitingPrimary

Centralized Prescribing for Statins

NCT05874726Active Not Recruiting

Biological Sample Repository for Gastrointestinal Disorders

NCT04488497Not ApplicableCompleted

Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:

NCT06055036Not ApplicableRecruiting

Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention

Scroll to load more

Research Network

Activity Timeline